ALLOS THERAPEUTICS INC Operating Income
ALLOS THERAPEUTICS INC reported Operating Income of -$7.99 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-08-03
- ALLOS THERAPEUTICS INC operating income (loss) for the quarter ending 2012-06-30 was -$7.99M.
- ALLOS THERAPEUTICS INC operating income (loss) for the quarter ending 2012-03-31 was -$11.32M.
- ALLOS THERAPEUTICS INC operating income (loss) for the quarter ending 2011-12-31 was -$1.43M.
- ALLOS THERAPEUTICS INC operating income (loss) for the quarter ending 2011-09-30 was -$11.41M.
- ALLOS THERAPEUTICS INC operating income (loss) for fiscal 2011 was -$30.62M.
- ALLOS THERAPEUTICS INC operating income (loss) for fiscal 2010 was -$79.02M.
- ALLOS THERAPEUTICS INC operating income (loss) for fiscal 2009 was -$74.01M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2012-06-30 | -$7.99M 10-Q · filed 2012-08-03 | -$19.31M 10-Q · filed 2012-08-03 | -$20.75M derived: sum of 3 quarters · filed 2012-08-03 | -$32.16M derived: sum of 4 quarters · filed 2012-08-03 | |||
| 2012-03-31 | -$11.32M 10-Q · filed 2012-05-03 | -$12.75M derived: sum of 2 quarters · filed 2012-05-03 | -$24.16M derived: sum of 3 quarters · filed 2012-05-03 | -$26.70M derived: sum of 4 quarters · filed 2012-08-03 | |||
| 2011-12-31 | -$1.43M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$12.84M derived: sum of 2 quarters · filed 2012-03-26 | -$15.38M derived: sum of 3 quarters · filed 2012-08-03 | -$30.62M 10-K · filed 2012-03-26 | |||
| 2011-09-30 | -$11.41M 10-Q/A · filed 2012-03-26 | -$11.27M 10-Q · filed 2011-11-03 | -$13.94M derived: sum of 2 quarters · filed 2012-08-03 | -$29.18M 10-Q/A · filed 2012-03-26 | -$24.37M 10-Q · filed 2011-11-03 | -$48.84M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-06-30 | -$2.54M 10-Q · filed 2012-08-03 | $2.14M 10-Q · filed 2011-08-04 | -$17.78M 10-Q · filed 2012-08-03 | -$13.10M 10-Q · filed 2011-08-04 | -$37.44M derived: sum of 3 quarters · filed 2012-08-03 | -$56.16M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-03-31 | -$15.24M 10-Q · filed 2012-05-03 | -$34.90M derived: sum of 2 quarters · filed 2012-05-03 | -$53.62M derived: sum of 3 quarters · filed 2012-05-03 | -$73.64M derived: sum of 4 quarters · filed 2012-05-03 | |||
| 2010-12-31 | -$19.66M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$38.38M derived: sum of 2 quarters · filed 2012-03-26 | -$58.40M derived: sum of 3 quarters · filed 2012-03-26 | -$79.02M 10-K · filed 2012-03-26 | |||
| 2010-09-30 | -$18.72M 10-Q/A · filed 2012-03-26 | -$38.74M derived: sum of 2 quarters · filed 2012-03-26 | -$59.35M 10-Q/A · filed 2012-03-26 | ||||
| 2010-06-30 | -$20.02M 10-Q/A · filed 2012-03-26 | -$40.63M 10-Q/A · filed 2012-03-26 | |||||
| 2009-12-31 | -$74.01M 10-K · filed 2012-03-26 |